Seer Reports First Quarter 2023 Financial Results
09 mai 2023 16h05 HE
|
Seer, Inc.
Grew revenue 22% year-over-year with continued growth in installed base and an increasing number of customer presentations and publications REDWOOD CITY, Calif., May 09, 2023 (GLOBE NEWSWIRE) --...
Seer to Report First Quarter 2023 Financial Results on May 9, 2023
20 avr. 2023 16h05 HE
|
Seer, Inc.
REDWOOD CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will...
Seer’s Proteograph™ Product Suite identifies undiscovered links between protein variants and lung cancer progression
29 mars 2023 14h00 HE
|
Seer, Inc.
REDWOOD CITY, Calif., March 29, 2023 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced a new scientific...
Seer Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Outlook
02 mars 2023 16h05 HE
|
Seer, Inc.
REDWOOD CITY, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
Seer to Present at the Cowen 43rd Annual Health Care Conference
21 févr. 2023 16h30 HE
|
Seer, Inc.
REDWOOD CITY, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company...
Seer to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
09 févr. 2023 16h05 HE
|
Seer, Inc.
REDWOOD CITY, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will...
Seer to Present at the J.P. Morgan 41st Annual Health Care Conference
27 déc. 2022 16h05 HE
|
Seer, Inc.
REDWOOD CITY, Calif., Dec. 27, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company...
Seer’s Proteomics Platform Named as Top 10 Innovation in 2022 by The Scientist
12 déc. 2022 10h00 HE
|
Seer, Inc.
REDWOOD CITY, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the...
Seer Reports Third Quarter 2022 Financial Results
08 nov. 2022 16h05 HE
|
Seer, Inc.
REDWOOD CITY, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
Seer to Report Third Quarter 2022 Financial Results on November 8, 2022
13 oct. 2022 16h15 HE
|
Seer, Inc.
REDWOOD CITY, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report...